<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-43297" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vitamin B6 Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hemminger</surname>
            <given-names>Adam</given-names>
          </name>
          <aff>Virginia Commonwealth University Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wills</surname>
            <given-names>Brandon K.</given-names>
          </name>
          <aff>Virginia Commonwealth University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adam Hemminger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brandon Wills declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-43297.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>This activity describes the toxicity associated with vitamin B6 at higher doses. It explains in detail the pathophysiology and toxicokinetics of vitamin B6 toxicity and patient symptoms. This activity reviews the evaluation and treatment of vitamin B6 toxicity and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of vitamin B6 toxicity.</p></list-item><list-item><p>Outline an appropriate evaluation for suspected vitamin B6 toxicity.</p></list-item><list-item><p>Review a reasonable differential diagnosis for patients presenting with signs and symptoms of pyridoxine toxicity.</p></list-item><list-item><p>Select the treatment and management options available to the healthcare team for vitamin B6 toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43297&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43297">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-43297.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Vitamin B6 is a micronutrient required by the body. Vitamin B6 refers to multiple chemically similar compounds, of which pyridoxine is the most common and is the compound found in commercially available vitamin supplements. The body uses vitamin B6 in numerous enzymatic reactions, including neurotransmitter production, amino acid metabolism, glucose metabolism, lipid metabolism, hemoglobin synthesis and function, and gene expression.<xref ref-type="bibr" rid="article-43297.r1">[1]</xref>&#x000a0;In the United States, vitamin B6 intake from food averages about 1.9 mg/day.<xref ref-type="bibr" rid="article-43297.r2">[2]</xref>&#x000a0;Intake of food-based sources of pyridoxine will not cause toxicity.&#x000a0;The only reported cases of vitamin B6 toxicity are from supratherapeutic dosing of supplements or iatrogenic.</p>
      </sec>
      <sec id="article-43297.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Almost all cases of vitamin B6 toxicity are from supratherapeutic dosing, either iatrogenic or laypersons self-treating with over-the-counter supplements. Daily dietary intake will not provide enough pyridoxine to cause&#x000a0;toxicity. The daily dietary intake of vitamin B6 is approximately 1.9 mg/day in the United States.<xref ref-type="bibr" rid="article-43297.r2">[2]</xref>&#x000a0;Additionally, typical pyridoxine doses used for co-treatment with isoniazid are 10 to 25 mg/day. Pyridoxine toxicity typically manifests as neurologic symptoms, including paresthesias in the extremities and, in severe cases, difficulty with ambulation. This sensory neuropathy usually develops at doses of pyridoxine above 1000 mg per day. There are some case reports of sensory neuropathies at doses of less than 500 mg per day in patients taking supplements for months. However, none of the studies had sensory nerve damage at a daily intake below 200 mg of pyridoxine per day.<xref ref-type="bibr" rid="article-43297.r3">[3]</xref>&#x000a0;A rare cause of vitamin B toxicity is hypophosphatasia.<xref ref-type="bibr" rid="article-43297.r4">[4]</xref></p>
      </sec>
      <sec id="article-43297.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Vitamin B6 supplementation is a therapeutic option for a variety of medical conditions. Pyridoxine is used in supratherapeutic doses as an antidote to treat seizures from isoniazid toxicity.<xref ref-type="bibr" rid="article-43297.r5">[5]</xref>&#x000a0;It is used in therapeutic doses for hyperemesis gravidarum&#x000a0;and isoniazid.<xref ref-type="bibr" rid="article-43297.r6">[6]</xref><xref ref-type="bibr" rid="article-43297.r7">[7]</xref>&#x000a0;It is used as a nutritional supplement by the lay public for a variety of perceived health benefits, including morning sickness, cardiovascular disease, premenstrual syndrome, depression, and carpal tunnel syndrome.&#x000a0;Evidence for efficacy for many of these uses is mixed.</p>
        <p>Over-the-counter supplements are the most likely culprit for patients taking a pyridoxine level above the safe recommended upper limit. Often patients are unaware that high-dose pyridoxine could be harmful. One illustrative case report describes a patient presenting to a healthcare facility with peripheral neuropathy, and he reported taking vitamin B-complex supplements at fifty times the daily suggested allowance for ten years.<xref ref-type="bibr" rid="article-43297.r8">[8]</xref>&#x000a0;According to the 2017 United States Poison Center data, there were 566 reports of using pyridoxine therapeutically as an antidote.<xref ref-type="bibr" rid="article-43297.r9">[9]</xref>&#x000a0;Additionally, 377 pyridoxine exposure cases were reported, including eight cases with only minor or moderate clinical effects. There were no serious outcomes or deaths reported.</p>
      </sec>
      <sec id="article-43297.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Paradoxically the most common symptoms associated with vitamin B6 toxicity are similar to those with vitamin B6 deficiency. A patient will experience peripheral sensory neuropathy. Most commonly, this causes numbness in a stocking-glove distribution over the extremities. In addition to peripheral neuropathy, patients can experience ataxia and disequilibrium as well.<xref ref-type="bibr" rid="article-43297.r10">[10]</xref>&#x000a0;One large study found that patients also could experience hyperesthesia, bone pains, muscle weakness, numbness, and fasciculations.<xref ref-type="bibr" rid="article-43297.r11">[11]</xref></p>
        <p>One study examined the role of pyridoxine toxicity on human cells to examine the neurotoxic effects further. They found that pyridoxine induced cell death in a concentration-dependent fashion and inhibited pyridoxal-5-phosphate-dependent enzymes.<xref ref-type="bibr" rid="article-43297.r12">[12]</xref>&#x000a0;Thus it appears that the inactive form of B6, pyridoxine, competitively inhibits the active vitamin B6 form, pyridoxal-5&#x02019;-phosphate causing the symptoms of vitamin B6 toxicity to mimic the symptoms of vitamin B6 deficiency.</p>
      </sec>
      <sec id="article-43297.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>After oral ingestion of pyridoxine, peak plasma levels are achieved in approximately one hour.<xref ref-type="bibr" rid="article-43297.r11">[11]</xref>&#x000a0;In the liver and other tissues, absorbed vitamin B6 forms are converted by the liver to pyridoxal 5&#x02019;-phosphate (PLP) and transported in the serum bound to albumin.<xref ref-type="bibr" rid="article-43297.r13">[13]</xref>&#x000a0;In oral doses of 100 mg of pyridoxine, pyridoxal, and pyridoxamine, the majority are excreted unchanged in the urine.<xref ref-type="bibr" rid="article-43297.r14">[14]</xref>&#x000a0;Several drugs have interactions with vitamin B6 and can interfere with their levels. These medications typically lower the level of pyridoxine and lead to vitamin B6 deficiency and not toxicity. Isoniazid, cycloserine, penicillamine, and L-dopa all form complexes with vitamin B6, limiting its bioavailability. Oral contraceptives are associated with lower pyridoxine phosphate levels in a subset of women.<xref ref-type="bibr" rid="article-43297.r15">[15]</xref>&#x000a0;High doses of pyridoxine may decrease the blood levels of phenytoin and phenobarbital.<xref ref-type="bibr" rid="article-43297.r3">[3]</xref></p>
      </sec>
      <sec id="article-43297.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History and physical exams are essential for identifying patients with vitamin B6 toxicity. Most patients will have neurologic symptoms and be seeking an evaluation for sensory neuropathy.&#x000a0;A detailed medication reconciliation, including over-the-counter supplements, is needed.&#x000a0;Since many over-the-counter supplements can have different doses of pyridoxine, having patients bring in medication and supplement bottles can be beneficial to ascertain the exact dosage of vitamins in a particular product. The physical examination should include a thorough neurologic exam, including sensory, motor, gait, reflexes, cranial nerve testing, and muscle strength. Patients will typically present with bilateral sensory or motor changes, although a unilateral presentation is possible if there has been previous trauma or neurologic injury to an extremity.</p>
      </sec>
      <sec id="article-43297.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Serum pyridoxine levels are typically less than 30 mcg/L. Patients with signs or symptoms of neuropathy should receive a referral to neurology or other specialists who can perform nerve conduction velocity studies.&#x000a0;The diagnostic evaluation will typically start with the patient reporting signs and symptoms of peripheral sensory neuropathy.&#x000a0;The workup of peripheral neuropathy is important to evaluate and rule out other etiologies of neuropathy.</p>
      </sec>
      <sec id="article-43297.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no specific treatment or antidote for pyridoxine toxicity. Treatment involves cessation of&#x000a0;supplemental pyridoxine promptly following diagnosis, symptomatic management, and supportive care for any continued or irreversible symptoms. This could include physical therapy when appropriate.</p>
        <p>Also, the recommended daily allowance for different age groups should be kept in mind while prescribing B-6:</p>
        <list list-type="bullet">
          <list-item>
            <p>0.5 to 1 mg in children</p>
          </list-item>
          <list-item>
            <p>1.3 mg daily for young&#x000a0;adults</p>
          </list-item>
          <list-item>
            <p>1.7 mg daily for men older than 50&#x000a0;</p>
          </list-item>
          <list-item>
            <p>0.5 mg daily for women older than 50&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43297.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of vitamin B6 toxicity is broad and includes deficiency or toxicity of other vitamins, including vitamin B12 as the symptoms are similar. Other causes of peripheral neuropathy merit consideration include diabetes mellitus, autoimmune disorders (lupus), chronic liver disease, end-stage liver disease, HIV/AIDS, hypothyroidism, Lyme disease, lymphoma, monoclonal gammopathy, syphilis, porphyria, drugs (amiodarone, digoxin, lithium, isoniazid), and toxins (heavy metals, ethanol, organophosphates). Exposure history and the temporal course will help differentiate many of these etiologies.&#x000a0; Additional laboratory testing and nerve conduction velocity studies may also be helpful.</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetes mellitus</p>
          </list-item>
          <list-item>
            <p>Autoimmune disorders (lupus)</p>
          </list-item>
          <list-item>
            <p>Chronic liver disease</p>
          </list-item>
          <list-item>
            <p>Human immunodeficiency virus/acquired immunodeficiency virus</p>
          </list-item>
          <list-item>
            <p>Hypothyroidism</p>
          </list-item>
          <list-item>
            <p>Lyme disease</p>
          </list-item>
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Monoclonal gammopathy</p>
          </list-item>
          <list-item>
            <p>Syphilis</p>
          </list-item>
          <list-item>
            <p>Porphyria</p>
          </list-item>
          <list-item>
            <p>Drugs</p>
          </list-item>
          <list-item>
            <p>Toxins, including other vitamins</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43297.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis is usually favorable, with symptoms resolving or decreasing when&#x000a0;supratherapeutic pyridoxine has been discovered and stopped.&#x000a0;Neuropathy from massive exposures can cause long-term disability or death. Neurologic dysfunction improves following discontinuation of vitamin B&#x000a0;supplementation and usually resolves within 6 months. Some patients do not recover.</p>
      </sec>
      <sec id="article-43297.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Patients typically experience symptoms of peripheral neuropathy,&#x000a0;dermatoses, photosensitivity, dizziness, and nausea with long-term intake of dosages above 250 mg/day. Additional morbidity would include ataxia and dysesthesias.</p>
      </sec>
      <sec id="article-43297.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should receive education regarding vitamins and minerals derived from their daily diet. Counseling should be provided to patients interested in supplementing pyridoxine and discussing risk with higher-end dosing. Medical professionals employing pyridoxine as therapy will typically use smaller doses.</p>
      </sec>
      <sec id="article-43297.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Other valuable information concerning vitamin B6 toxicity include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vitamin B6 is used to treat multiple medical conditions and is available as a supplement over the counter.</p>
          </list-item>
          <list-item>
            <p>Vitamin B6 toxicity symptoms mimic vitamin B6 deficiency.</p>
          </list-item>
          <list-item>
            <p>The classic presentation of pyridoxine toxicity is peripheral sensory neuropathy.</p>
          </list-item>
          <list-item>
            <p>It is helpful to obtain a thorough history and ask about supplements and dosages.</p>
          </list-item>
          <list-item>
            <p>Vitamin B6 toxicity is seen with vitamin supplements but not from dietary intake of foodstuffs.</p>
          </list-item>
          <list-item>
            <p>Symptoms generally improve after discontinuing supplementation.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43297.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Healthcare is a team enterprise consisting of multiple medical professions, and various interactions within this process influence patient care and outcomes. The most crucial factor for pyridoxine toxicity is to recognize peripheral neuropathy as a critical feature.&#x000a0;This will trigger a comprehensive interview to get additional information on past medical history, medications, supplements, and occupational and environmental exposure history.&#x000a0; Allied health professionals can assist in patient care outcomes by completing the medical history and current medications and supplements. Obtaining a detailed vitamin supplement history, including drug names, dosages, and length of time a patient has been taking medication, can be a key aspect in identifying vitamin B6 toxicity.</p>
      </sec>
      <sec id="article-43297.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43297&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43297">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/nutrition/vitamin-b6-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=43297">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/43297/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=43297">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-43297.s17">
        <title>References</title>
        <ref id="article-43297.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zuo</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>ZY</given-names>
              </name>
            </person-group>
            <article-title>A comprehensive toxicity evaluation in rats after long-term oral Gelsemium elegans exposure.</article-title>
            <source>Biomed Pharmacother</source>
            <year>2021</year>
            <month>May</month>
            <volume>137</volume>
            <fpage>111284</fpage>
            <pub-id pub-id-type="pmid">33561641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Picciano</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Jacques</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Selhub</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2008</year>
            <month>May</month>
            <volume>87</volume>
            <issue>5</issue>
            <fpage>1446</fpage>
            <page-range>1446-54</page-range>
            <pub-id pub-id-type="pmid">18469270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bender</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Non-nutritional uses of vitamin B6.</article-title>
            <source>Br J Nutr</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-20</page-range>
            <pub-id pub-id-type="pmid">10341670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whyte</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wenkert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Bijanki</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Ericson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Coburn</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Hypophosphatasia: Vitamin B<sub>6</sub> status of affected children and adults.</article-title>
            <source>Bone</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>154</volume>
            <fpage>116204</fpage>
            <pub-id pub-id-type="pmid">34547524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Wills</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Neurotoxic emergencies.</article-title>
            <source>Neurol Clin</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>539</fpage>
            <page-range>539-63</page-range>
            <pub-id pub-id-type="pmid">21803209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McParlin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Beyer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moloney</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Muirhead</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Nelson-Piercy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Newbury-Birch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Norman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Swallow</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Oct</month>
            <day>04</day>
            <volume>316</volume>
            <issue>13</issue>
            <fpage>1392</fpage>
            <page-range>1392-1401</page-range>
            <pub-id pub-id-type="pmid">27701665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Snider</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine supplementation during isoniazid therapy.</article-title>
            <source>Tubercle</source>
            <year>1980</year>
            <month>Dec</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-6</page-range>
            <pub-id pub-id-type="pmid">6269259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silva</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>D'Cruz</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine toxicity courtesy of your local health food store.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>1666</fpage>
            <page-range>1666-7</page-range>
            <pub-id pub-id-type="pmid">17105856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gummin</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Mowry</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Spyker</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Osterthaler</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Banner</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>12</issue>
            <fpage>1213</fpage>
            <page-range>1213-1415</page-range>
            <pub-id pub-id-type="pmid">30576252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albin</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Albers</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Lynn</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Alessi</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Acute sensory neuropathy-neuronopathy from pyridoxine overdose.</article-title>
            <source>Neurology</source>
            <year>1987</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>1729</fpage>
            <page-range>1729-32</page-range>
            <pub-id pub-id-type="pmid">2823181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of pyridoxine overdose neuropathy syndrome.</article-title>
            <source>Acta Neurol Scand</source>
            <year>1987</year>
            <month>Jul</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-11</page-range>
            <pub-id pub-id-type="pmid">3630649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vrolijk</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Opperhuizen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>EHJM</given-names>
              </name>
              <name>
                <surname>Hageman</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Bast</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haenen</surname>
                <given-names>GRMM</given-names>
              </name>
            </person-group>
            <article-title>The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function.</article-title>
            <source>Toxicol In Vitro</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>44</volume>
            <fpage>206</fpage>
            <page-range>206-212</page-range>
            <pub-id pub-id-type="pmid">28716455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Plecko</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Clayton</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>Disorders affecting vitamin B<sub>6</sub> metabolism.</article-title>
            <source>J Inherit Metab Dis</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>629</fpage>
            <page-range>629-646</page-range>
            <pub-id pub-id-type="pmid">30671974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ink</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B6 metabolism.</article-title>
            <source>Annu Rev Nutr</source>
            <year>1984</year>
            <volume>4</volume>
            <fpage>455</fpage>
            <page-range>455-70</page-range>
            <pub-id pub-id-type="pmid">6380540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43297.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rios-Avila</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Coats</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ralat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chi</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Midttun</surname>
                <given-names>&#x000d8;</given-names>
              </name>
              <name>
                <surname>Ueland</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Stacpoole</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Gregory</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine supplementation does not alter in vivo kinetics of one-carbon metabolism but modifies patterns of one-carbon and tryptophan metabolites in vitamin B-6-insufficient oral contraceptive users.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>102</volume>
            <issue>3</issue>
            <fpage>616</fpage>
            <page-range>616-25</page-range>
            <pub-id pub-id-type="pmid">26201817</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
